医药前沿
醫藥前沿
의약전연
Yiayao Qianyan
2015年
25期
23-23,24
,共2页
支气管镜%耐多药肺结核%辅助治疗
支氣管鏡%耐多藥肺結覈%輔助治療
지기관경%내다약폐결핵%보조치료
Bronchoscopy%Multi drug resistant pulmonary tuberculosis%Adjuvant therapy
目的：研究分析采用支气管镜注药辅助治疗耐多药肺结核的临床效果。方法：选取本院2013年1月-12月收治的耐多药肺结核患者100例，分为对照组与研究组，其中对照组给予全身化疗治疗，研究组在对照组基础上给予支气管镜注药辅助治疗，比较两组患者痰菌转阴率、病灶吸收率、肺结核空洞闭合率。结果：治疗6个月后研究组痰菌转阴率、病灶吸收率以及肺结核空洞闭合率明显高于对照组，差异具有统计学意义（P<0.05)。结论：支气管镜注药辅助治疗耐多药肺结核效果显著，值得临床广泛推广。
目的：研究分析採用支氣管鏡註藥輔助治療耐多藥肺結覈的臨床效果。方法：選取本院2013年1月-12月收治的耐多藥肺結覈患者100例，分為對照組與研究組，其中對照組給予全身化療治療，研究組在對照組基礎上給予支氣管鏡註藥輔助治療，比較兩組患者痰菌轉陰率、病竈吸收率、肺結覈空洞閉閤率。結果：治療6箇月後研究組痰菌轉陰率、病竈吸收率以及肺結覈空洞閉閤率明顯高于對照組，差異具有統計學意義（P<0.05)。結論：支氣管鏡註藥輔助治療耐多藥肺結覈效果顯著，值得臨床廣汎推廣。
목적：연구분석채용지기관경주약보조치료내다약폐결핵적림상효과。방법：선취본원2013년1월-12월수치적내다약폐결핵환자100례，분위대조조여연구조，기중대조조급여전신화료치료，연구조재대조조기출상급여지기관경주약보조치료，비교량조환자담균전음솔、병조흡수솔、폐결핵공동폐합솔。결과：치료6개월후연구조담균전음솔、병조흡수솔이급폐결핵공동폐합솔명현고우대조조，차이구유통계학의의（P<0.05)。결론：지기관경주약보조치료내다약폐결핵효과현저，치득림상엄범추엄。
ObjectiveTo study and analyze the clinical effect of multi drug resistant pulmonary tuberculosis by bronchoscopy. MethodsSelected 100 cases of pulmonary tuberculosis patients with multi drug resistant admitted in our hospital they were divided into control group and study group, the control group was treated with systemic chemotherapy, study group used bronchoscopy injection adjuvant therapy based on control group, Comparison of clinical efficacy.ResultsAfter 6 months treatment, study group’s sputum negative conversion rate, focus absorption rate as well as the pulmonary tuberculosis cavity closure rate were significantly higher than control group, the difference with significant statistical significance (P < 0.05).ConclusionThe clinical effect of the treatment of multi drug resistant pulmonary tuberculosis with bronchoscopy is notable, and it is worthy of clinical application.
